Status:

ACTIVE_NOT_RECRUITING

A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity

Lead Sponsor:

Novo Nordisk A/S

Conditions:

Obesity

Overweight

Eligibility:

All Genders

18-55 years

Phase:

PHASE1

Brief Summary

The study is testing a new study medicine to treat people living with overweight or obesity. The aim of this study is to see if the medicine is safe, how it works in your body, and what your body does...

Eligibility Criteria

Inclusion

  • Key inclusion criteria
  • Male or female.
  • Age 18-55 years (both inclusive) at the time of signing the informed consent.
  • BMI between 25.0 and 34.9 kg/m\^2 (both inclusive) at screening. Overweight should be due to excess adipose tissue, as judged by the investigator.
  • Considered to be generally healthy based on the medical history, physical examination, and the results of vital signs, electrocardiogram and clinical laboratory tests performed during the screening visit, as judged by the investigator.
  • Key exclusion criteria
  • Known or suspected hypersensitivity to study intervention(s) or related products.
  • Any condition, which in the investigator's opinion might jeopardise participant's safety or compliance with the protocol.
  • HbA1c greater than or equal to 6.5 percentage (48 mmol/mol) at screening.
  • Any laboratory safety parameters at screening outside the below laboratory ranges, see designated reference range documents for specific values:
  • Vitamin D (25-hydroxycholecalciferol) less than 12 ng/mL (30 nM) at screening
  • Parathyroid hormone (PTH) outside normal range at screening
  • Total calcium outside normal range at screening

Exclusion

    Key Trial Info

    Start Date :

    September 3 2024

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 24 2026

    Estimated Enrollment :

    88 Patients enrolled

    Trial Details

    Trial ID

    NCT06577766

    Start Date

    September 3 2024

    End Date

    September 24 2026

    Last Update

    December 23 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    ICON

    San Antonio, Texas, United States, 78209